Metraipolis › archive › dc_a2ff2f2749c7

Evaluating the efficacy and safety of tebentafusp in the treatment of metastatic uveal melanoma: a 2025 update systematic review and meta-analysis — Europe PMC PMID:41170451

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41170451
DOI
10.3389/fonc.2025.1667282
License (as archived)
solo-consultazione
Archived
2026-11-09T07:12:46.400Z
SHA-256 of the archived text
8933ee71c22c9b5f8a3156d7d9d3cc450aa29d3a4aeaceed2599c0693dcb6874
Stable URL of this page
https://metraipolis.com/documento/dc_a2ff2f2749c7

How to cite

Evaluating the efficacy and safety of tebentafusp in the treatment of metastatic uveal melanoma: a 2025 update systematic review and meta-analysis — Europe PMC PMID:41170451 — Europe PMC (en), https://europepmc.org/article/MED/41170451 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_a2ff2f2749c7 (Metraipolis archive dc_a2ff2f2749c7, sha256 8933ee71c22c9b5f8a3156d7d9d3cc450aa29d3a4aeaceed2599c0693dcb6874)
BibTeX
@misc{dca2ff2f2749c7,
  title = {Evaluating the efficacy and safety of tebentafusp in the treatment of metastatic uveal melanoma: a 2025 update systematic review and meta-analysis — Europe PMC PMID:41170451},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41170451},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_a2ff2f2749c7; sha256 8933ee71c22c9b5f8a3156d7d9d3cc450aa29d3a4aeaceed2599c0693dcb6874},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41170451. Agents can read the archived copy with the MCP tool read_document.